Biological active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular diseases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Becker, 2004, New concepts in reactive oxygen species and cardiovascular reperfusion physiology, Cardiovasc. Res., 61, 461, 10.1016/j.cardiores.2003.10.025
Blessberger, 2018, Perioperative beta-blockers for preventing surgery-related mortality and morbidity, Cochrane Database Syst. Rev., 3
Cao, 2019, Evidence of astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients, Medicines (Basel), 98, e14798
Cao, 2020, Astragaloside and/or hydroxysafflor yellow A attenuates oxygen-glucose deprivation-induced cultured brain microvessel endothelial cell death through downregulation of PHLPP-1, Evid. Based Complement. Alternat. Med. 2020, 10.1155/2020/3597527
Chang, 2012, The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues, J. Chromatogr., 911, 71
Chen, 2017, PG2 for patients with acute spontaneous intracerebral hemorrhage: a double-blind, randomized, placebo-controlled study, Sci. Rep., 7, 45628, 10.1038/srep45628
Chen, 1995, Effects of Astragalus membranaceus on left ventricular function and oxygen free radical in acute myocardial infarction patients and mechanism of its cardiotonic action, Chin. J. Integr. Med., 15, 141
Chen, 2019, Astragaloside VI promotes neural stem cell proliferation and enhances neurological function recovery in transient cerebral ischemic injury via activating EGFR/MAPK signaling cascades, Mol. Neurobiol., 56, 3053, 10.1007/s12035-018-1294-3
Cheng, 2019, Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway, Life Sci, 227, 82, 10.1016/j.lfs.2019.04.040
Cheng, 2015, Plant natural products calycosin and gallic acid synergistically attenuate neutrophil infiltration and subsequent injury in isoproterenol-induced myocardial infarction: a possible role for leukotriene B4 12-hydroxydehydrogenase?, Oxid. Med. Cell. Longev., 2015, 10.1155/2015/434052
Chiu, 2014, Beneficial effect of astragalosides on stroke condition using PC12 cells under oxygen glucose deprivation and reperfusion, Cell. Mol. Neurobiol., 34, 825, 10.1007/s10571-014-0059-4
Choi, 2007, Alleviation of osteoarthritis by calycosin-7-O-beta-d-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model, Osteoarthritis Cartilage, 15, 1086, 10.1016/j.joca.2007.02.015
Chouchani, 2014, Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS, Nature, 515, 431, 10.1038/nature13909
Dai, 2014, Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades, Environ. Toxicol. Pharmacol., 38, 263, 10.1016/j.etap.2014.05.008
Dieterle, 2015, Side effects and interactions of frequently used cardiovascular drugs, Ther. Umsch., 72, 701, 10.1024/0040-5930/a000740
Dimmeler, 1998, Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis?, Eur. Cytokine Netw., 9, 697
Dong, 2017, Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation, Sci. Rep., 7, 2691, 10.1038/s41598-017-02360-5
Dou, 2021, Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition, Front. Med., 15, 79, 10.1007/s11684-020-0783-8
Dow, 2016, Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study, Clin. Ophthalmol., 10, 243, 10.2147/OPTH.S100042
Du, 2019, Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5, Biomed. Pharmacother., 116, 10.1016/j.biopha.2019.109028
Du, 2021, Astragaloside IV attenuates cerebral ischemia‑reperfusion injury in rats through the inhibition of calcium‑sensing receptor‑mediated apoptosis, Int. J. Mol. Med., 47, 302, 10.3892/ijmm.2020.4777
Du, 2005, Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry, Eur. J. Drug Metab. Pharmacokinet., 30, 269, 10.1007/BF03190631
Ettehad, 2016, Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis, Lancet, 387, 957, 10.1016/S0140-6736(15)01225-8
Falk, 2006, Pathogenesis of atherosclerosis, J. Am. Coll. Cardiol., 47, C7, 10.1016/j.jacc.2005.09.068
Fares, 2017, Introduction: challenges and advances in cardiovascular disease, Cleve. Clin. J. Med., 84, 11, 10.3949/ccjm.84.s3.01
Fernandez, 2018, TA-65, a telomerase activator improves cardiovascular markers in patients with metabolic syndrome, Curr. Pharm. Des., 24, 1905, 10.2174/1381612824666180316114832
Ford-Hutchinson, 1980, Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature, 286, 264, 10.1038/286264a0
Fu, 2014, Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi), Phytother. Res., 28, 1275, 10.1002/ptr.5188
Fu, 2014, Calycosin-7-O-β-d-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury, J. Ethnopharmacol., 155, 692, 10.1016/j.jep.2014.06.015
Fu, 2011, Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review, PLoS ONE, 6, e19604, 10.1371/journal.pone.0019604
Gallagher, 2019, A systematic review of clinical prediction rules for the diagnosis of chronic heart failure, ESC Heart Fail, 6, 499, 10.1002/ehf2.12426
Gao, 2014, Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali, Pharm. Biol., 52, 1217, 10.3109/13880209.2013.879188
Gao, 2019, Regularity of traditional Chinese medicine prescriptions for same treatment for cardiovascular and cerebrovascular diseases, China J. Chin. Mater. Med., 44, 193
Ghafouri-Fard, 2020, Non-coding RNAs participate in the ischemia-reperfusion injury, Biomed Pharmacother, 129, 10.1016/j.biopha.2020.110419
Gong, 2018, Evaluation of the pharmaceutical properties and value of Astragali Radix, Medicines (Basel), 5, 46, 10.3390/medicines5020046
Gu, 2004, Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali, Basic Clin. Pharmacol. Toxicol., 95, 295, 10.1111/j.1742-7843.2004.t01-1-pto950508.x
Guo, 2012, Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats, J. Ethnopharmacol., 144, 768, 10.1016/j.jep.2012.09.056
Guo, 2019, A systematic review of phytochemistry, pharmacology and pharmacokinetics on Astragali Radix: implications for Astragali Radix as a personalized medicine, Int. J. Mol. Sci., 20, 1463, 10.3390/ijms20061463
Han, 2016, Protective effects of Astragalus polysaccharides against endothelial dysfunction in hypertrophic rats induced by isoproterenol, Int. Immunopharmacol., 38, 306, 10.1016/j.intimp.2016.06.014
Harley, 2013, A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response, Rejuvenation Res, 16, 386, 10.1089/rej.2013.1430
Hsu, 2020, Calycosin preserves BDNF/TrkB signaling and reduces post-stroke neurological injury after cerebral ischemia by reducing accumulation of hypertrophic and TNF-α-Containing microglia in rats, J. Neuroimmune Pharmacol., 15, 326, 10.1007/s11481-019-09903-9
Huang, 2020, Calycosin reduces infarct size, oxidative stress and preserve heart function in isoproterenol-induced myocardial infarction model, Pak. J. Pharm. Sci., 33, 1341
Huang, 2021, A single, acute astragaloside IV therapy protects cardiomyocyte through attenuating superoxide anion-mediated accumulation of autophagosomes in myocardial ischemia-reperfusion injury, Front. Pharmacol., 12
Ji, 2018, Astragalosides increase the cardiac diastolic function and regulate the "Calcium sensing receptor-protein kinase C-protein phosphatase 1" pathway in rats with heart failure, Biomed. Pharmacother., 103, 838, 10.1016/j.biopha.2018.04.111
Jiang, 2000, Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells, Proc. Natl. Acad. Sci. U. S. A., 97, 1749, 10.1073/pnas.040560897
Jiang, 2019, Astragaloside IV attenuates myocardial ischemia-reperfusion injury from oxidative stress by regulating succinate, lysophospholipid metabolism, and ROS scavenging system, Oxid. Med. Cell. Longev., 2019, 10.1155/2019/9137654
Jiangbo, 2009, Effect of astragaloside IV on the embryo-fetal development of Sprague-Dawley rats and New Zealand White rabbits, J. Appl. Toxicol., 29, 381, 10.1002/jat.1422
Jin, 1991, Effect of Astragalus membranaceus on erythrocyte sodium content and sodium transport in the coronary heart disease, Chin. J. Integr. Med., 11, 651
Johnson, 2002, Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases, Science, 298, 1911, 10.1126/science.1072682
Jolly, 1986, Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion, Am. Heart J., 112, 682, 10.1016/0002-8703(86)90461-8
Junqing, 2015, Effect of calycosin on left ventricular ejection fraction and angiogenesis in rat models with myocardial infarction, J. Tradit. Chin. Med., 35, 160, 10.1016/S0254-6272(15)30023-6
Katsur, 2021, Exosomes from neuronal stem cells may protect the heart from ischaemia/reperfusion injury via JAK1/2 and gp130, J. Cell. Mol. Med., 25, 4455, 10.1111/jcmm.16515
Koskinas, 2016, Regression of coronary atherosclerosis: current evidence and future perspectives, Trends Cardiovasc. Med., 26, 150, 10.1016/j.tcm.2015.05.004
Le, 2014, Absorption and transportation of calycosin in Astragali Radix by using Caco-2 monolayer model, China J. Chin. Mater. Med., 39, 1709
Lei, 2021, The novel Nrf2 activator CDDO-EA attenuates cerebral ischemic injury by promoting microglia/macrophage polarization toward M2 phenotype in mice, CNS Neurosci. Ther., 27, 82, 10.1111/cns.13496
Levy, 2017, The epigenetic machinery in vascular dysfunction and hypertension, Curr. Hypertens. Rep., 19, 52, 10.1007/s11906-017-0745-y
Li, 2020, Efficiency of Traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway, Biomed. Pharmacother., 126, 10.1016/j.biopha.2020.110074
Li, 2021, Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway, Ann. Transl. Med., 9, 1435, 10.21037/atm-21-4080
Li, 2018, Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice, Toxicol. Appl. Pharmacol., 340, 58, 10.1016/j.taap.2017.12.019
Li, 2005, Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats, Chin. J. Physiol., 48, 101
Li, 2020, Structural characterization and immune activity screening of polysaccharides with different molecular weights from Astragali Radix, Front. Pharmacol., 11
Li, 2021, Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats, Int. Immunopharmacol., 92, 10.1016/j.intimp.2020.107335
Li, 2020, Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia, Acta Pharmacol. Sin., 41, 1025, 10.1038/s41401-020-0386-6
Li, 2013, Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4, Eur. J. Pharmacol., 715, 189, 10.1016/j.ejphar.2013.05.022
Li, 2012, Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules, Neurochem. Int., 60, 458, 10.1016/j.neuint.2012.01.026
Li, 2017, Calycosin Inhibits the Migration and Invasion of Human Breast Cancer Cells by Down-Regulation of Foxp3 Expression, Cell. Physiol. Biochem., 44, 1775, 10.1159/000485784
Li, 1995, Clinical observation on the treatment of ischemic heart disease with Astragalus membranaceus, Chin. J. Integr. Med., 15, 77
Li, 2014, A review of recent research progress on the astragalus genus, Molecules, 19, 18850, 10.3390/molecules191118850
Li, 2019, Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II. Free Radic, Biol. Med., 131, 251
Liang, 2020, Astragaloside IV regulates the HIF/VEGF/Notch signaling pathway through miRNA-210 to promote angiogenesis after ischemic stroke, Restor. Neurol. Neurosci., 38, 271
Lin, 2018, Astragaloside IV Improves Vasodilatation Function by Regulating the PI3K/Akt/eNOS Signaling Pathway in Rat Aorta Endothelial Cells, J. Vasc. Res., 55, 169, 10.1159/000489958
Litt, 1989, Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 min of ischemia. Evidence for neutrophil-mediated reperfusion injury, Circulation, 80, 1816, 10.1161/01.CIR.80.6.1816
Liu, 2017, Anti-aging implications of Astragalus Membranaceus (Huangqi): a well-known Chinese tonic, Aging Dis., 8, 868, 10.14336/AD.2017.0816
Liu, 2018, Astragaloside IV protects against the pathological cardiac hypertrophy in mice, Biomed. Pharmacother., 97, 1468, 10.1016/j.biopha.2017.09.092
Lu, 2018, Calcium sensing receptor-related pathway contributes to cardiac injury and the mechanism of astragaloside IV on cardioprotection, Front. Pharmacol., 9, 1163, 10.3389/fphar.2018.01163
Lu, 2015, Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway, Phytother. Res., 29, 599, 10.1002/ptr.5297
Lu, 2014, Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway, Planta Med, 80, 63
Luo, 2019, Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function, Chem. Biol. Interact., 309, 10.1016/j.cbi.2019.06.036
Ma, 2017, Pharmacokinetics, metabolism, and excretion of cycloastragenol, a potent telomerase activator in rats, Xenobiotica, 47, 526, 10.1080/00498254.2016.1204568
Matkowski, 2003, Flavonoids and phenol carboxylic acids in the oriental medicinal plant Astragalus membranaceus acclimated in Poland, Z. Naturforsch. C J. Biosci., 58, 602, 10.1515/znc-2003-7-826
Mei, 2015, Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation, Environ. Toxicol. Pharmacol., 40, 764, 10.1016/j.etap.2015.09.007
Meyer, 1999, Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species, Endothelium, 7, 11, 10.3109/10623329909165308
Napolitano, 2005, Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages, Eur. J. Clin. Invest., 35, 482, 10.1111/j.1365-2362.2005.01523.x
Ni, 2020, Astragaloside IV improves neurobehavior and promotes hippocampal neurogenesis in MCAO rats though BDNF-TrkB signaling pathway, Biomed. Pharmacother., 130, 10.1016/j.biopha.2020.110353
Nie, 2019, Astragaloside IV exerts a myocardial protective effect against cardiac hypertrophy in rats, partially via activating the Nrf2/HO-1 signaling pathway, Oxid. Med. Cell. Longev., 2019, 10.1155/2019/4625912
Pai, 2010, Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line, Oncol. Lett., 1, 339, 10.3892/ol_00000060
Pasterkamp, 2004, Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease, Eur. J. Clin. Invest., 34, 328, 10.1111/j.1365-2362.2004.01338.x
Qin, 2021, Protective effects of astragaloside IV against hypertension-induced vascular remodeling involves the DNMT1 and TET2 signaling pathway, Arch. Biol. Sci., 73, 303, 10.2298/ABS210426024Q
Ren, 2016, Calycosin‑7‑O‑β‑D‑glucoside attenuates ischemia‑reperfusion injury in vivo via activation of the PI3K/Akt pathway, Mol. Med. Report., 13, 633, 10.3892/mmr.2015.4611
Ren, 2020, Application quantitative proteomics approach to identify differentially expressed proteins associated with cardiac protection mediated by cycloastragenol in acute myocardial infarction rats, J. Proteomics, 222, 10.1016/j.jprot.2020.103691
Salvador, 2016, A natural product telomerase activator lengthens telomeres in humans: a randomized, double blind, and placebo controlled study, Rejuvenation Res, 19, 478, 10.1089/rej.2015.1793
Shao, 2021, Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro, Mol. Cell. Biochem., 476, 1783, 10.1007/s11010-020-04035-8
Sheu, 2014, Novel drugs development for cardio-/cerebrovascular diseases, Biomed Res. Int., 2014, 10.1155/2014/467936
Shi, 2021, Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway, J. Food Biochem., 45, e13757, 10.1111/jfbc.13757
Shi, 2016, SGLT-1 transport and deglycosylation inside intestinal cells are key steps in the absorption and disposition of calycosin-7-O-β-d-glucoside in rats, Drug Metab. Dispos., 44, 283, 10.1124/dmd.115.067009
Shi, 2015, Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali radix using UPLC-MS/MS, J. Ethnopharmacol., 169, 183, 10.1016/j.jep.2015.04.019
Shi, 2021, Neuroprotective effect of astragaloside IV on cerebral ischemia/reperfusion injury rats through Sirt1/Mapt pathway, Front. Pharmacol., 12
Song, 2014, Pharmacokinetic interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats, Planta Med, 80, 187, 10.1055/s-0033-1360261
Song, 2007, Development of microwave assisted extraction for the simultaneous determination of isoflavonoids and saponins in radix astragali by high performance liquid chromatography, J. Sep. Sci., 30, 819, 10.1002/jssc.200600340
Squizzato, 2017, Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events, Cochrane Database Syst. Rev., 12
Strohm, 2000, Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium, J. Cardiovasc. Pharmacol., 36, 218, 10.1097/00005344-200008000-00012
Su, 2021, Phytochemistry and cardiovascular protective effects of Huang-Qi (Astragali Radix), Med. Res. Rev., 41, 1999, 10.1002/med.21785
Sui, 2019, Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway, Pharm. Biol., 57, 48, 10.1080/13880209.2019.1569697
Sui, 2020, The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure, Pharm. Biol., 58, 1192, 10.1080/13880209.2020.1849319
Sun, 2021, Astragaloside IV ameliorates myocardial infarction induced apoptosis and restores cardiac function, Front. Cell Dev. Biol., 9
Sun, 2020, Astragaloside IV exerts cognitive benefits and promotes hippocampal neurogenesis in stroke mice by downregulating interleukin-17 expression via Wnt pathway, Front. Pharmacol., 11, 421, 10.3389/fphar.2020.00421
Szabo, 2014, Dietary safety of cycloastragenol from Astragalus spp.: subchronic toxicity and genotoxicity studies, Food Chem. Toxicol., 64, 322, 10.1016/j.fct.2013.11.041
Tang, 2018, Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure, Biosci. Rep., 38, 10.1042/BSR20171036
Tang, 2021, Review of natural resources with vasodilation: traditional medicinal plants, natural products, and their mechanism and clinical efficacy, Front. Pharmacol., 12, 10.3389/fphar.2021.627458
Tfelt-Hansen, 2006, Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes, Am. J. Physiol. Heart Circ. Physiol., 290, H1165, 10.1152/ajpheart.00821.2005
Thompson, 2000, Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs, Pediatr. Res., 47, 669, 10.1203/00006450-200005000-00019
Wan, 2018, Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome, Eur. J. Pharmacol., 833, 545, 10.1016/j.ejphar.2018.06.016
Wang, 2012, Study of the effects of total flavonoids of Astragalus on atherosclerosis formation and potential mechanisms, Oxid. Med. Cell. Longev., 2012, 10.1155/2012/282383
Wang, 2019, Protective effects of astragaloside IV against LPS-Induced endometritis in mice through inhibiting activation of the NF-κB, p38 and JNK signaling pathways, Molecules, 24, 373, 10.3390/molecules24020373
Wang, 2017, Astragaloside IV for experimental focal cerebral ischemia: preclinical evidence and possible mechanisms, Oxid. Med. Cell. Longev., 2017, 10.1155/2017/8424326
Wang, 2018, Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling, Biomed. Pharmacother., 107, 1074, 10.1016/j.biopha.2018.08.016
Wang, 2017, Huangqi injection in the treatment of chronic heart failure: a systematic review and meta-analysis, Medicine (Baltimore), 96, e8167, 10.1097/MD.0000000000008167
Wang, 2020, Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling, Biomed. Pharmacother., 123, 10.1016/j.biopha.2019.109729
Wang, 2015, Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment, J. Neuroinflammation, 12, 80, 10.1186/s12974-015-0301-0
Wang, 2014, Downregulated RASD1 and upregulated miR-375 are involved in protective effects of calycosin on cerebral ischemia/reperfusion rats, J. Neurol. Sci., 339, 144, 10.1016/j.jns.2014.02.002
Wang, 2020, Antitumor effects of immunity-enhancing traditional Chinese medicine, Biomed. Pharmacother., 121, 10.1016/j.biopha.2019.109570
Wang, 2010, Protective effect of Astragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha, Phytother. Res., 24, 393, 10.1002/ptr.2958
Weeks, 2017, The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection, Adv. Exp. Med. Biol., 1000, 187, 10.1007/978-981-10-4304-8_12
Wu, 2006, Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta, Acta Pharmacol. Sin., 27, 1007, 10.1111/j.1745-7254.2006.00349.x
Wu, 2020, Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a, Mol. Cell. Biochem., 470, 41, 10.1007/s11010-020-03743-5
Xu, 2013, Pharmacokinetics and tolerance of toal astragalosides after intravenous infusion of astragalosides injection in healthy Chinese volunteers, Phytomedicine, 20, 1105, 10.1016/j.phymed.2013.05.004
Xu, 2018, Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice, J. Microbiol., 56, 838, 10.1007/s12275-018-8327-5
Xu, 2020, Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway, Pharmacology, 105, 181, 10.1159/000503361
Xue, 2019, Astragaloside IV protects primary cerebral cortical neurons from oxygen and glucose deprivation/reoxygenation by activating the PKA/CREB pathway, Neuroscience, 404, 326, 10.1016/j.neuroscience.2019.01.040
Xue, 2008, Effect of total flavonoid fraction of Astragalus complanatus R. Brown on angiotensin II-induced portal-vein contraction in hypertensive rats, Phytomedicine, 15, 759, 10.1016/j.phymed.2007.11.030
Xuying, 2010, Effect of astragaloside IV on the general and peripartum reproductive toxicity in Sprague-Dawley rats, Int. J. Toxicol., 29, 505, 10.1177/1091581810376840
Yan, 2019, Calycosin-7-O-β-d-glucoside attenuates OGD/R-Induced damage by preventing oxidative stress and neuronal apoptosis via the SIRT1/FOXO1/PGC-1α pathway in HT22 cells, Neural Plast, 2019, 10.1155/2019/8798069
Yang, 2021, Protective effects of Astragaloside IV against oxidative injury and apoptosis in cultured astrocytes by regulating Nrf2/JNK signaling. Exp, Brain Res, 239, 1827, 10.1007/s00221-021-06096-7
Yang, 2013, Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy, J. Ethnopharmacol., 150, 1062, 10.1016/j.jep.2013.10.017
Yang, 2020, Astragaloside IV enhances GATA-4 mediated myocardial protection effect in hypoxia/reoxygenation injured H9c2 cells, Nutr. Metab. Cardiovasc. Dis., 30, 829, 10.1016/j.numecd.2020.01.009
Yang, 2010, Effects of astragalus on cardiac function and serum tumor necrosis factor-alpha level in patients with chronic heart failure, Chin. J. Integr. Med., 30, 699
Yin, 2019, Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways, Acta Pharmacol. Sin., 40, 599, 10.1038/s41401-018-0082-y
Yin, 2020, Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway, J. Ethnopharmacol., 248, 10.1016/j.jep.2019.112319
Yokomizo, 2001, Leukotriene B4: metabolism and signal transduction, Arch. Biochem. Biophys., 385, 231, 10.1006/abbi.2000.2168
Yu, 2019, Uncovering the pharmacological mechanism of Carthamus tinctorius L. on cardiovascular disease by a systems pharmacology approach, Biomed. Pharmacother., 117, 10.1016/j.biopha.2019.109094
Yu, 2019, Astragaloside IV protects neurons from microglia-mediated cell damage through promoting microglia polarization, Folia Neuropathol, 57, 170, 10.5114/fn.2019.86299
Yu, 2017, Astragaloside attenuates myocardial injury in a rat model of acute myocardial infarction by upregulating hypoxia inducible factor‑1α and Notch1/Jagged1 signaling, Mol. Med. Report., 15, 4015, 10.3892/mmr.2017.6522
Yu, 2021, Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury, Aging (Albany N. Y.), 13, 16804
Yu, 2018, Astragaloside IV reduces the hypoxia-induced injury in PC-12 cells by inhibiting expression of miR-124, Biomed. Pharmacother., 106, 419, 10.1016/j.biopha.2018.06.127
Yu, 2018, Cycloastragenol: an exciting novel candidate for age-associated diseases, Exp. Ther. Med., 16, 2175
Zeng, 2018, Simultaneous quantification of multiple components in rat plasma by UPLC-MS/MS and pharmacokinetic study after oral administration of Huangqi decoction, Biomed. Chromatogr., 32, e4178, 10.1002/bmc.4178
Zhang, 2017, Correlation between quantitative analysis of wall shear stress and intima-media thickness in atherosclerosis development in carotid arteries, Biomed. Eng. Online, 16, 137, 10.1186/s12938-017-0425-9
Zhang, 2007, Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings, Clin. Exp. Pharmacol. Physiol., 34, 387, 10.1111/j.1440-1681.2007.04564.x
Zhang, 2020, Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism, Pharm. Biol., 58, 328, 10.1080/13880209.2020.1746362
Zhang, 2018, Analysis on research and development of global cardiovascular drugs in the past 6 years, J. China Pharm. U., 49, 760
Zhang, 2002, Clinical study on effect of Astragalus injection on left ventricular remodeling and left ventricular function in patients with acute myocardial infarction, Chin. J. Integr. Med., 22, 346
Zhang, 2015, Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review, Mini Rev. Med. Chem., 15, 315, 10.2174/1389557515666150227113431
Zhang, 2007, Pharmacokinetics of astragaloside iv in beagle dogs, Eur. J. Drug Metab. Pharmacokinet., 32, 75, 10.1007/BF03190995
Zhang, 2017, Knockout of Eva1a leads to rapid development of heart failure by impairing autophagy, Cell Death Dis, 8, e2586, 10.1038/cddis.2017.17
Zhang, 2015, Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis, PLoS ONE, 10
Zhang, 2020, Astragaloside IV prevents myocardial hypertrophy induced by mechanical stress by activating autophagy and reducing inflammation, Am. J. Transl. Res., 12, 5332
Zhang, 2006, Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs, Life Sci, 79, 808, 10.1016/j.lfs.2006.02.032
Zhang, 2006, Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways, Planta Med, 72, 621, 10.1055/s-2006-931572
Zhang, 2019, The role of astragaloside IV against cerebral ischemia/reperfusion injury: suppression of apoptosis via promotion of P62-LC3-autophagy, Molecules, 24, 1838, 10.3390/molecules24091838
Zhao, 2013, Negative regulation of TBK1-mediated antiviral immunity, FEBS Lett, 587, 542, 10.1016/j.febslet.2013.01.052
Zhao, 2018, Astragaloside protects myocardial cells from apoptosis through suppression of the TLR4/NF-κB signaling pathway, Exp. Ther. Med., 15, 1505
Zheng, 2020, Pharmacokinetic analysis of Huangqi Guizhi Wuwu Decoction on blood and brain tissue in rats with normal and cerebral ischemia-reperfusion injury by microdialysis with HPLC-MS/MS, Drug Des. Devel. Ther., 14, 2877, 10.2147/DDDT.S257020
Zheng, 2018, A preclinical systematic review and meta-analysis of astragaloside IV for myocardial ischemia/reperfusion injury, Front. Physiol., 9, 795, 10.3389/fphys.2018.00795
Zheng, 2020, A review of the pharmacological action of Astragalus Polysaccharide, Front. Pharmacol., 11, 349, 10.3389/fphar.2020.00349
Zhu, 2010, In vitro intestinal absorption and first-pass intestinal and hepatic metabolism of cycloastragenol, a potent small molecule telomerase activator, Drug Metab. Pharmacokinet., 25, 477, 10.2133/dmpk.DMPK-10-RG-037
Zhu, 2014, Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in rats, PLoS ONE, 9, e93334, 10.1371/journal.pone.0093334
Zhu, 2013, Astragalus polysaccharides suppress ICAM-1 and VCAM-1 expression in TNF-α-treated human vascular endothelial cells by blocking NF-κB activation, Acta Pharmacol. Sin., 34, 1036, 10.1038/aps.2013.46